Xofluza (baloxavir marboxil) 40mg tabs
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75A50324F80013-LSJ
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79723D0219-75A50324F80013 Federal contract award
- Awardee
- Genentech Usa, Inc.
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- South San Francisco, California 94080, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice is for the federal procurement of Xofluza (baloxavir marboxil) 40mg tablets by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The contract, valued at an unknown amount, was awarded on September 27, 2024 to an unknown vendor under contract number 36F79723D0219. The procurement falls under the NAICS code for Pharmaceutical Preparation Manufacturing and the PSC code for Drugs And Biologicals. No other details regarding required quantities, pricing terms, or the rationale for the limited/sole source justification are provided in the information given.
Notice text
Xofluza (baloxavir marboxil) 40mg tablets.
Awarded contract 36F79723D0219 to unknown vendor for unknown amount on 2024-09-27.
Files
| File | Type | Posted |
|---|---|---|
| LSJ_Baloxavir - Xofluza_SAM.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity